The Impact of Apollo-Era Microbiology on Human Space FlightThe microbiota of crewmembers and the spacecraft environment contributes significant risk to crew health during space flight missions. NASA reduces microbial risk with various mitigation methods that originated during the Apollo Program and continued to evolve through subsequent programs: Skylab, Shuttle, and International Space Station (ISS). A quarantine of the crew and lunar surface samples, within the Lunar Receiving Laboratory following return from the Moon, was used to prevent contamination with unknown extraterrestrial organisms. The quarantine durations for the crew and lunar samples were 21 days and 50 days, respectively. A series of infections among Apollo crewmembers resulted in a quarantine before launch to limit exposure to infectious organisms. This Health Stabilization Program isolated the crew for 21 days before flight and was effective in reducing crew illness. After the program developed water recovery hardware for Apollo spacecraft, the 1967 National Academy of Science Space Science Board recommended the monitoring of potable water. NASA implemented acceptability limits of 10 colony forming units (CFU) per mL and the absence of viable E. coli, anaerobes, yeasts, and molds in three separate 150 mL aliquots. Microbiological investigations of the crew and spacecraft environment were conducted during the Apollo program, including the Apollo-Soyuz Test Project and Skylab. Subsequent space programs implemented microbial screening of the crew for pathogens and acceptability limits on spacecraft surfaces and air. Microbiology risk mitigation methods have evolved since the Apollo program. NASA cancelled the quarantine of the crew after return from the lunar surface, reduced the duration of the Health Stabilization Program; and implemented acceptability limits for spacecraft surfaces and air. While microbial risks were not a main focus of the early Mercury and Gemini programs, the extended duration of Apollo flights resulted in the increased scrutiny of impact of the space flight environment on crew health. The lessons learned during that era of space flight continue to impact microbiology risk mitigation in space programs today.
Document ID
20140005965
Acquisition Source
Johnson Space Center
Document Type
Presentation
Authors
Elliott, T. F (Wyle Integrated Science and Engineering Group Houston, TX, United States)
Castro, V. A. (Wyle Integrated Science and Engineering Group Houston, TX, United States)
Bruce, R. J. (Enterprise Advisory Services, Inc. Houston, TX, United States)
Pierson, D. L. (NASA Johnson Space Center Houston, TX, United States)
Date Acquired
May 20, 2014
Publication Date
May 17, 2014
Subject Category
Aerospace MedicineLife Sciences (General)
Report/Patent Number
JSC-CN-31225Report Number: JSC-CN-31225
Meeting Information
Meeting: American Society for Microbiology 2014 Annual Meeting